Neuropsychiatric manifestations of prostate cancer and its treatment: Biological mechanisms and psycho-oncology perspectives
Year: 2026
Type: article
Abstract: Prostate cancer (PCa) is the most frequently diagnosed malignancy in men and a leading cause of cancer-related mortality worldwide. Beyond its oncological burden, PCa is increasingly recognized as a condition with profound psychiatric and neurocognitive implications. Depression, anxiety, sleep disturbance and cognitive decline are highly prevalent among patients, particularly those undergoing androgen deprivation therapy or chemotherapy. The most consistent clinical evidence suggests associations between androgen deprivation therapy and mood-related morbidity, whereas findings for cognition and proposed mechanisms such as inflammation, oxidative stress, hypothalamic-pituitary-adrenal axis dysregulation and altered neural signaling remain heterogeneous and are not uniformly supported by PCa-specific prospective studies. Addressing these dimensions requires a holistic, multidisciplinary model of care in which mental health screening and psychiatric support are integrated into oncology practice. PCa thus serves as a paradigm for understanding the bidirectional relationship between chronic disease, treatment-induced biological stress and psychiatric health. This narrative review links evidence on treatment-related neuropsychiatric outcomes, proposed biological mechanisms, neuroimaging findings, societal aspects of neuropsychiatric morbidity in PCa, while also highlighting important areas for integrated care and future research. Sources such as PubMed/MEDLINE, Scopus, Web of Science, PsycINFO, Google Scholar and reference-list screening were used to identify English-language peer-reviewed literature published from January 2000 to November 2025.
Source: World Journal of Psychiatry
DOI: 10.5498/wjp.125256
Authors: Shivani Bhave, Yash Darji, Akhilesh Prajapati
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: prostate cancer, neuropsychiatric symptoms, depression, anxiety, sleep disorders, cognitive decline, androgen deprivation therapy, chemotherapy, hypothalamic-pituitary-adrenal axis, neuroinflammation, oxidative stress, neuroimaging, psycho-oncology, mental health screening, integrated care
Open Access status: diamond
OpenAlex ID: W7220975322
